Skip to main content
SpringerLink
Log in

Oral Lupus Erythematosus

  • Chapter
  • First Online:
Diseases of the Oral Mucosa

  • 1801 Accesses

Abstract

Oral manifestations are commonly seen in patients with lupus erythematosus. They more frequently occur in childhood and systemic lupus erythematosus compared with cutaneous lupus. The lesions may start in the lips and can involve all part of the oral cavity with preference of the hard and soft palate and the buccal mucosa. They include well-demarcated erythema or erosion, oral ulcers that may be surrounded by white radiating striae as well as discoid plaques or papules. Diagnostic procedure should include a full anamneses and laboratory investigation for cutaneous and systemic lupus manifestations. Important differential diagnoses include infections, lichen planus, cancer and other autoimmune disorders. Topical treatment can be complemented by systemic treatment of accompanying cutaneous and systemic lupus lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Menzies S, O’Shea F, Galvin S, Wynne B. Oral manifestations of lupus. Irish J Med Sci (1971-). 2018;187(1):91–3.

    Article  CAS  Google Scholar 

  2. Ahola K, Saarinen A, Kuuliala A, Leirisalo-Repo M, Murtomaa H, Meurman JH. Impact of rheumatic diseases on oral health and quality of life. Oral Dis. 2015;21(3):342–8.

    Article  CAS  Google Scholar 

  3. Benli M, Batool F, Stutz C, Petit C, Jung S, Huck O. Orofacial manifestations and dental management of systemic lupus erythematosus: a review. Oral Dis. 2019;27(2):151–67.

    Google Scholar 

  4. Sontheimer RD. The lexicon of cutaneous lupus erythematosus--a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus. 1997;6(2):84–95.

    Article  CAS  Google Scholar 

  5. Nico MM, Vilela MA, Rivitti EA, Lourenco SV. Oral lesions in lupus erythematosus: correlation with cutaneous lesions. Eur J Dermatol. 2008;18(4):376–81.

    PubMed  Google Scholar 

  6. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European league against rheumatism/American College of Rheumatology Classification Criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–12.

    Article  Google Scholar 

  7. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981;4(4):471–5.

    Article  CAS  Google Scholar 

  8. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7.

    Article  CAS  Google Scholar 

  9. Jonsson R, Heyden G, Westberg NG, Nyberg G. Oral mucosal lesions in systemic lupus erythematosus--a clinical, histopathological and immunopathological study. J Rheumatol. 1984;11(1):38–42.

    CAS  PubMed  Google Scholar 

  10. Del Barrio-Díaz P, Reyes-Vivanco C, Cifuentes-Mutinelli M, Manríquez J, Vera-Kellet C. Association between oral lesions and disease activity in lupus erythematosus. J Eur Acad Dermatol Venereol. 2020;34(2):349–56.

    Article  Google Scholar 

  11. Rodsaward P, Prueksrisakul T, Deekajorndech T, Edwards SW, Beresford MW, Chiewchengchol D. Oral ulcers in juvenile-onset systemic lupus erythematosus: a review of the literature. Am J Clin Dermatol. 2017;18(6):755–62.

    Article  Google Scholar 

  12. Kuhn A, Sigges J, Biazar C, Ruland V, Patsinakidis N, Landmann A, et al. Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database. Br J Dermatol. 2014;171(3):571–9.

    Article  CAS  Google Scholar 

  13. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. Arthritis Rheum. 2002;46(7):1830–9.

    Article  CAS  Google Scholar 

  14. Alperin JM, Ortiz-Fernandez L, Sawalha AH. Monogenic lupus: a developing paradigm of disease. Front Immunol. 2018;9:2496.

    Article  Google Scholar 

  15. Gunther C. Genetics of lupus erythematosus. Hautarzt. 2015;66(2):121–8.

    Article  Google Scholar 

  16. Kwon YC, Chun S, Kim K, Mak A. Update on the genetics of systemic lupus erythematosus: genome-wide association studies and beyond. Cells. 2019;8(10):1180.

    Article  CAS  Google Scholar 

  17. Wolf C, Bruck N, Koss S, Griep C, Kirschfink M, Palm-Beden K, et al. Janus kinase inhibition in complement component 1 deficiency. J Allergy Clin Immunol. 2020;146(6):1439–42.

    Article  CAS  Google Scholar 

  18. Gunther C, Kind B, Reijns MA, Berndt N, Martinez-Bueno M, Wolf C, et al. Defective removal of ribonucleotides from DNA promotes systemic autoimmunity. J Clin Invest. 2015;125(1):413–24.

    Article  Google Scholar 

  19. Peschke K, Friebe F, Zimmermann N, Wahlicht T, Schumann T, Achleitner M, et al. Deregulated type I IFN response in TREX1-associated familial chilblain lupus. J Invest Dermatol. 2014;134(5):1456–9.

    Article  CAS  Google Scholar 

  20. Nico MM, Bologna SB, Lourenço SV. The lip in lupus erythematosus. Clin Exp Dermatol. 2014;39(5):563–9.

    Article  CAS  Google Scholar 

  21. Kranti K, Seshan H, Juliet J. Discoid lupus erythematosus involving gingiva. J Indian Soc Periodontol. 2012;16(1):126–8.

    Article  CAS  Google Scholar 

  22. Ranginwala AM, Chalishazar MM, Panja P, Buddhdev KP, Kale HM. Oral discoid lupus erythematosus: a study of twenty-one cases. J Oral Maxillofac Pathol. 2012;16(3):368–73.

    Article  Google Scholar 

  23. Khatibi M, Shakoorpour AH, Jahromi ZM, Ahmadzadeh A. The prevalence of oral mucosal lesions and related factors in 188 patients with systemic lupus erythematosus. Lupus. 2012;21(12):1312–5.

    Article  CAS  Google Scholar 

  24. Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Günther C, Iking-Konert C, Kreuter A, Müller-LadnerU, Nast A, Ochsendorf F, Schneider M, Sticherling M, Tenbrock K, Wenzel J, Kuhn A. S2k-Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes - Teil 1: Klassifikation, Diagnostik, Prävention und Aktivitätsscores. J Dtsch Dermatol Ges. 2021;19(8):1236–48.

    Google Scholar 

  25. Singh A, Verma R, Murari A, Agrawal A. Oral candidiasis: an overview. J Oral Maxillofac Pathol. 2014;18(Suppl 1):S81–S5.

    PubMed  PubMed Central  Google Scholar 

  26. Liu Z, Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med. 2012;18(6):871–82.

    Article  Google Scholar 

  27. Hejazi EZ, Werth VP. Cutaneous lupus erythematosus: an update on pathogenesis, diagnosis and treatment. Am J Clin Dermatol. 2016;17(2):135–46.

    Article  Google Scholar 

  28. Gunther C. Nucleic acid immunity in the pathogenesis of cutaneous lupus erythematosus. Front Immunol. 2019;10:1636.

    Article  Google Scholar 

  29. Wenzel J, Worenkamper E, Freutel S, Henze S, Haller O, Bieber T, et al. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol. 2005;205(4):435–42.

    Article  CAS  Google Scholar 

  30. Kuhn A, Aberer E, Bata-Csorgo Z, Caproni M, Dreher A, Frances C, et al. S2k guideline for treatment of cutaneous lupus erythematosus – guided by the European dermatology forum (EDF) in cooperation with the European academy of dermatology and venereology (EADV). J Eur Acad Dermatol Venereol. 2017;31(3):389–404.

    Article  CAS  Google Scholar 

  31. Günther C, Aringer M. Belimumab internistische praxis. 2017;57:355–9.

    Google Scholar 

  32. Navarra SV, Guzman RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377(9767):721–31.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany

    Claudia Günther

Authors
  1. Claudia Günther
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudia Günther .

Editor information

Editors and Affiliations

  1. Lübeck Institute of Experimental Dermatology (LIED) and Department of Dermatology, University of Lübeck, Lübeck, Germany

    Enno Schmidt

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Günther, C. (2021). Oral Lupus Erythematosus. In: Schmidt, E. (eds) Diseases of the Oral Mucosa. Springer, Cham. https://doi.org/10.1007/978-3-030-82804-2_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-82804-2_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-82803-5

  • Online ISBN: 978-3-030-82804-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation